Denis Drygin
Keine laufenden Positionen mehr
Karriereverlauf von Denis Drygin
Ehemalige bekannte Positionen von Denis Drygin
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
REGULUS THERAPEUTICS INC. | Technik-/Wissenschafts-/F&E-Leiter | 03.08.2020 | 29.11.2022 |
Pimera, Inc.
Pimera, Inc. Financial ConglomeratesFinance Pimera, Inc. provides investment services. The company is headquartered in San Diego, CA. | Gründer | 01.01.2013 | 31.07.2020 |
Corporate Officer/Principal | 01.01.2013 | 31.07.2020 | |
Cylene Pharmaceuticals, Inc.
Cylene Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cylene Pharmaceuticals, Inc. discovers, develops and commercializes small molecule drugs. It develops molecule drugs to treat life-threatening diseases, with a particular emphasis in oncology. The firm drug discovery platform, STAND has delivered a diverse portfolio of drug candidates that target the multiple pathways critical for the support, maintenance of cancer cells and that address unmet medical needs with substantial markets. The company was founded in 1997 by Thomas James Farrell and Daniel Douglas Von Hoff and is headquartered in San Diego, CA. | Corporate Officer/Principal | - | - |
Ausbildung von Denis Drygin
University of Massachusetts | Doctorate Degree |
Moscow State University Lomonosov | Graduate Degree |
Statistik
International
Vereinigte Staaten | 5 |
Russland | 2 |
Operativ
Corporate Officer/Principal | 2 |
Graduate Degree | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Sektoral
Health Technology | 3 |
Consumer Services | 3 |
Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
REGULUS THERAPEUTICS INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Pimera, Inc.
Pimera, Inc. Financial ConglomeratesFinance Pimera, Inc. provides investment services. The company is headquartered in San Diego, CA. | Finance |
Cylene Pharmaceuticals, Inc.
Cylene Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cylene Pharmaceuticals, Inc. discovers, develops and commercializes small molecule drugs. It develops molecule drugs to treat life-threatening diseases, with a particular emphasis in oncology. The firm drug discovery platform, STAND has delivered a diverse portfolio of drug candidates that target the multiple pathways critical for the support, maintenance of cancer cells and that address unmet medical needs with substantial markets. The company was founded in 1997 by Thomas James Farrell and Daniel Douglas Von Hoff and is headquartered in San Diego, CA. | Health Technology |
- Börse
- Insiders
- Denis Drygin
- Erfahrung